Results 171 to 180 of about 3,816 (188)

Tackling Substandard and Falsified Medicines in the Mekong: National Responses and Regional Prospects

Asia and the Pacific Policy Studies, 2015
Marco Liverani
exaly  

Unveiling the Peril of Substandard and Falsified Medicines to Public Health and Safety in Africa: Need for All-Out War to End the Menace

Medicine Access Point of Care, 2017
Abdulhakim Abubakar, Abubakar Sha'Aban, Nafiu Aminu   +2 more
exaly  

WHO report on substandard or falsified medicines

Reactions Weekly, 2017
openaire   +1 more source

India: Substandard medicines threaten the goal of zero malaria

2022
Taruna Arora, Amrita Chaudhary
openaire   +1 more source

Global health-care implications of substandard medicines

The Lancet Infectious Diseases, 2008
openaire   +1 more source

Phake: the deadly world of falsified and substandard medicines

Choice Reviews Online, 2014
openaire   +1 more source

Assessing the impact of substandard copy medicines in developing countries: the experience with imatinib copies

Expert Review of Clinical Pharmacology, 2013
Eleanor Hayes-Larson, Anna Kaltenboeck
exaly  

Economic cost of substandard and fake medicines in Tanzania

PharmacoEconomics & Outcomes News, 2018
openaire   +1 more source

Substandard and falsified medicines in African pharmaceutical markets: A case study from Ethiopia

Social Science and Medicine
Linda Gibson, Robert Dingwall, Bastiaens H   +2 more
exaly  

Screening for substandard and falsified medicines in Nigeria using visual inspection and GPHF-Minilab analysis: lessons learnt for future training of health workers and pharmacy personnel

Journal of Pharmaceutical Policy and Practice
Lutz Heide
exaly